For the year ending 2025-12-31, PMI had $11,355K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -27,002 |
| Depreciation and amortization | 163 |
| Amortization of right of use asset | 349 |
| Amortization of discount on debt issued | 4,525 |
| Derivative loss | -7,040 |
| Change in fair values of senior secured note and warrant liabilities | 1,017 |
| Financing charges from issuance of senior secured note | 2,294 |
| Provision for excess and obsolete inventory | 423 |
| Stock-based compensation | 754 |
| Accounts receivable | 120 |
| Inventories | -390 |
| Prepaid expenses and other assets | 250 |
| Accounts payable | -3,211 |
| Accrued expenses and other liabilities | 361 |
| Operating lease obligation | -372 |
| Net cash used in operating activities | -15,673 |
| Proceeds from loans from related parties | 3,909 |
| Payments to loans from related parties | 8,190 |
| Proceeds from notes payable | 13,500 |
| Financing costs paid | 1,488 |
| Proceeds from issuance of convertible notes | 2,000 |
| Repayment of convertible notes | 25 |
| Proceeds from issuance of common stock | 15,209 |
| Proceeds from subscription of common stock | 2,235 |
| Repayment of finance lease obligations | 72 |
| Net cash provided by financing activities | 27,078 |
| Effect of exchange rate changes on cash and cash equivalents | -50 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 11,355 |
| Cash, cash equivalents and restricted cash at beginning of the period | 96 |
| Cash, cash equivalents and restricted cash at end of the period | 11,451 |
Picard Medical, Inc. (PMI)
Picard Medical, Inc. (PMI)